Volume 2, Issue 1
Research Articlep. 91
Experience with refractory vitamin D resistant rickets and non-17 alkyl testosterone derivative anabolic agent
Author(s): Aamir Jalal Al-Mosawi
Appendices
Acknowledgement: Volume2; Issue1
Appendices
Appendices: Volume 2; Issue 1
Appendices
Glossary: Volume 2; Issue 1
Review Articlep. 141
The anandamide membrane transporter and the therapeutic implications of its inhibition
Author(s): Natalia Battista, Valeria Gasperi, Filomena Fezza and Mauro Maccarrone
Review Articlep. 121
Stromal cells as new therapeutic targets in rheumatoid arthritis
Author(s): Oliver Haworth, Angela Burman, Greg Parsonage, Andrew Filer, Mike Salmon and Christopher D Buckley
Review Articlep. 113
An overview of the beneficial cardiovascular effects of thiazolidinediones
Author(s): Fadi A El-Atat, John Nicasio, Luther T Clark and Samy I McFarlane
Research Articlep. 107
Short-term effect of sibutramine versus placebo on mood in depressed and non-depressed obese patients
Author(s): Kristina Elfhag and Stephan Rossner
Research Articlep. 95
Two-hour post dose cyclosporine monitoring does not fit all in kidney transplantation
Author(s): Dario Cattaneo, Flavio Gaspari, Stefania Zenoni, Sara Baldelli, Eliana Gotti, Annalisa Perna, Norberto Perico and Giuseppe Remuzzi
Editorialp. 1
Targeted lung cancer therapy: what have we learned from gefitinib?
Author(s): Peilin Zhang and John Rogers
Research Articlep. 77
Purine and nonpurine pharmacological CDK inhibitors target initiation of viral transcription
Author(s): Jonathan J Lacasse, Veronic MI Provencher, Matthew D Urbanowski and Luis M Schang
Short Reportp. 61
The mutant prevention concentration as a strategy to minimize antimicrobial resistance- a timely concept but will it\'s acceptance be too late?
Author(s): Glen T Hansen and Joseph M Blondeau
Short Reportp. 57
The changing role of thrombolytic therapy in the management of acute deep vein thrombosis
Author(s): Mahmood K Razavi and Charles P Semba
Drug Evaluationp. 37
Pimecrolimus for the treatment of atopic dermatitis
Author(s): Kristine Breuer, Thomas T Werfel & Alexander Kapp
Drug Evaluationp. 13
Adalimumab for the treatment of rheumatoid arthritis
Author(s): Susan J Lee and Arthur Kavanaugh
Drug Evaluationp. 7
Orlistat- An update after the first half decade of clinical experience
Author(s): Liam J Murphy
Bulletin Boardp. 3
